This inventor holds 58 USPTO granted patents and 15 published patent applications, plus 8 CIPO patents and 3 EPO patents, primarily in Ocular Therapeutics (CPC class A61K). Top assignees: Allergan, Inc., Allergan Sales, Inc., Akrivista LLC. Active years: 1993-2025.
Inventors with similar research interests:
Location History:
- Upland, CA (US) (1993)
- Trabuco Canyon, CA (US) (1994 - 2000)
- Coto de Coza, CA (US) (2003 - 2004)
- Cato De Caza, CA (US) (2004 - 2008)
- Coto de Caza, CA (US) (2001 - 2019)
- Reno, NV (US) (2023 - 2024)
Company Filing History:
45 out of 2,287 
5 out of 228 
3 out of 3 Years Active: 1993-2025
Areas of Expertise:
Title: The Innovations of Orest Olejnik in Ophthalmology
Introduction:
Orest Olejnik, a prolific inventor in the field of ophthalmology, hails from Coto de Caza, CA (US). With an impressive portfolio of 57 patents, his contributions have significantly impacted the diagnosis and treatment of various eye conditions, particularly dry eye syndrome.
Latest Patents:
Orest Olejnik's latest patents focus on methods of diagnosing and treating dry eye syndrome. His inventions revolve around ocular compositions tailored for treating dry eyes, encompassing a diverse range of natural oils. These compositions offer tailored solutions for patients with varying symptoms, enhancing the efficacy of treatment and comfort levels.
Career Highlights:
Throughout his career, Orest Olejnik has been associated with renowned companies such as Allergan, Inc. and Allergan Sales, Inc. These collaborations have provided him with a platform to further his research and innovation in the field of ophthalmology. His significant contributions have earned him recognition as a leading figure in the industry, known for his groundbreaking work in developing innovative solutions for eye care.
Collaborations:
During his tenure at Allergan, Inc. and Allergan Sales, Inc., Orest Olejnik had the privilege of working alongside esteemed colleagues such as James Nienyuan Chang and Patrick Michael Hughes. These collaborations have been instrumental in fostering a culture of innovation and knowledge-sharing, leading to the development of cutting-edge technologies in the realm of eye care.
Conclusion:
In conclusion, Orest Olejnik's pioneering work in ophthalmology, particularly in the realm of diagnosing and treating dry eye syndrome, stands as a testament to his relentless dedication to advancing healthcare solutions. His patents and collaborations reflect a commitment to excellence and a passion for creating impactful innovations that positively influence the lives of individuals suffering from eye conditions.